Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Several significant studies have been conducted to explore these aspects
This patented compound from Empower Pharmacy is a custom-compounded injectable that includes: Tirzepatide a dual glucosedependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend, and Food Intake In this clinical study, (6) test subjects were presented with GHRP-2 and then presented with unlimited food supply to measure food intake
Here is the complete unit reference chart for the 10mg dose across all common concentrations: Most compounded tirzepatide arrives at 10mg/mL or 20mg/mL
FDA have issued safety alerts about compounded GLP-1 products, including reports of dose errors, sterility issues and active ingredients that did not match the label
